E

Eton Pharmaceuticals

ETON

3.58000
USD
-0.06
(-1.65%)
مغلق
حجم التداول
2,906
الربح لكل سهم
0
العائد الربحي
0
P/E
-33
حجم السوق
222,708,078
أصول ذات صلة
A
AIHS
-0.03270
(-3.44%)
0.91730 USD
A
AKBA
-0.10000
(-7.25%)
1.28000 USD
I
IMMP
-0.09500
(-4.39%)
2.07000 USD
K
KTRA
-0.00020
(-0.09%)
0.22200 USD
K
KZIA
-0.02650
(-7.10%)
0.34700 USD
L
LPTX
-0.02000
(-0.93%)
2.12000 USD
R
REKR
-0.15000
(-8.24%)
1.67000 USD
S
SLS
0.08000
(6.90%)
1.24000 USD
S
STAF
-0.02000
(-1.02%)
1.94000 USD
T
TNXP
0.00960
(1.92%)
0.51050 USD
V
VBLT
-0.01140
(-6.65%)
0.16000 USD
الأخبار المقالات

العنوان: Eton Pharmaceuticals

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.